Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Akiko Saga-Kamo
Observed name:
A Saga-Kamo
Institution:
The University of Tokyo
Observed institution:
The University of Tokyo
ORCID:
0000-0002-0203-3792
Observed ORCID:
0000-0002-0203-3792
OpenAlex ID:
A5060964640
Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure
2017
·
Takehiro Kamo
, Hiroshi Akazawa
, et al.
·
PLoS ONE
·
265
PDF
Angiotensin II receptor blockade promotes repair of skeletal muscle through down-regulation of aging-promoting C1q expression
2015
·
Chizuru Yabumoto
, Hiroshi Akazawa
, et al.
·
Scientific Reports
·
54
PDF
Axitinib Induces and Aggravates Hypertension Regardless of Prior Treatment With Tyrosine Kinase Inhibitors
2021
·
Hiroshi Kadowaki
, Junichi Ishida
, et al.
·
Circulation Reports
·
9
PDF
XOR-Derived ROS in Tie2-Lineage Cells Including Endothelial Cells Promotes Aortic Aneurysm Progression in Marfan Syndrome
2025
·
Hiroki Yagi
, Hiroshi Akazawa
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
7
PDF
Protective action of the microbial metabolite butyrate against cardiomyocyte hypertrophy
2020
·
M Umei
, H Akazawa
, et al.
·
European Heart Journal
·
7
Inverse Agonist Activity of Angiotensin II Receptor Blocker Is Crucial for Prevention of Progressive Aortic Dilatation in Marfan Syndrome
2025
·
Hiroki Yagi
, Hiroshi Akazawa
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
5
PDF
Abstract P320: The Gut Microbial Metabolite Butyrate Suppresses Cardiac Hypertrophy Via An Epigenetic Mechanism
2021
·
Masahiko Umei
, Hiroshi Akazawa
, et al.
·
Circulation Research
Show more works
View as search
Works count:
7
Citation count:
347
H-index:
5
I10-index:
2
Year
Topic
Type